India Begins Phase 3 Clinical Trial for First Indigenous Dengue Vaccine
14 Aug 2024
The Indian Council of Medical Research (ICMR) and Panacea Biotec have launched India's first-ever Phase 3 clinical trial for a dengue vaccine. This groundbreaking trial aims to assess the efficacy of DengiAll, an indigenous tetravalent dengue vaccine developed by Panacea Biotec. The first participant received the vaccine on Wednesday at...
Read More
